Home > Healthcare > Biotechnology > Bioservices > Oncology Based In-vivo CRO Market

Oncology Based In-vivo CRO Market Share

Report ID: GMI12605
Published Date: Dec 2024
Report Format: PDF

Download Free Sample

Oncology Based In-vivo CRO Market Share

The global oncology-focused in-vivo CRO market exhibits intense competition, comprising both established global and regional companies. The market is fragmented with numerous companies providing specialized services across various aspects of in-vivo testing, including preclinical studies, efficacy testing, safety evaluations, and pharmacokinetics. While larger, established CROs maintain a dominant global presence, many regional players offer localized services, leveraging their deep understanding of specific oncology research requirements. Additionally, smaller CROs focus on niche areas such as immuno-oncology and preclinical efficacy studies, contributing to a diverse range of specialized services.

Oncology Based In-vivo CRO Market Companies

Some of the eminent market participants operating in the oncology based in-vivo CRO industry include:

Charles River Laboratories
Crown Bioscience
Eurofins Scientific
Evotec SE
ICON plc
IMV
Laboratory Corporation of America Holdings
Medidata
Merck KGaA
OncoOne
Pharmaron
Taconic Biosciences
The Jackson Laboratory
Thermo Fisher Scientific
WuXi AppTec.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global oncology-based in-vivo CRO industry was valued at USD 1.4 billion in 2024 and is projected to grow at an 8.8% CAGR from 2025 to 2034, driven by the increasing demand for immuno-oncology therapies.

The preclinical testing segment held a 33.2% market share in 2024 due to its essential role in the drug development process, mandated by regulatory agencies like the U.S. FDA and EMA.

The U.S. led the North American oncology-based in-vivo CRO market in 2024, generating approximately USD 509 million, primarily due to significant investments in cancer research and a strong presence of pharmaceutical and biotechnology companies.

Key players in the market include Charles River Laboratories, Crown Bioscience, Eurofins Scientific, Evotec SE, ICON plc, IMV, Laboratory Corporation of America Holdings, Medidata, Merck KGaA, OncoOne, Pharmaron, and Taconic Biosciences.